Skip to content

Hyperemesis in Pregnancy study

Hyperemesis in Pregnancy study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN56847191
Enrollment
50
Registered
2006-07-11
Start date
2004-03-01
Completion date
Unknown
Last updated
2016-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperemesis gravidarum / severe nausea and vomiting in pregnancy Pregnancy and Childbirth Hyperemesis gravidarum

Interventions

On admission, all women will be offered an anti-emetic injection (cyclizine lactate, 50 mg), and given an advice leaflet detailing helpful measures to reduce symptoms. They will be given a study infor

Sponsors

Newcastle upon Tyne Hospitals NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Any woman attending the maternity assessment unit under 20 weeks gestation suffering from moderate or severe nausea and vomiting

Exclusion criteria

Exclusion criteria: 1. Poor/no English 2. Over 20 weeks gestation 3. Under 16 year old or over 45 years 4. No treatment warranted 5. Women with significant medical conditions, e.g., insulin-dependent diabetes mellitus (IDDM), renal disease, cardiac disease 6. Women not suitable for out-patient management 7. Three admissions or more in the same week

Design outcomes

Primary

MeasureTime frame
Whether rapid rehydration administered over six hours in a day care setting, combined with out-patient psychological support reduces in-patient stay and improves women's quality of life.

Secondary

MeasureTime frame
The cost consequences of rapid rehydration on an out-patient basis compared to the current policy of routine admission.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026